Publications by authors named "H M Badran"

This study presents a comprehensive evaluation of Copper Indium Gallium Selenide (CIGS) solar technology, benchmarked against crystalline silicon (c-Si) PERC PV technology. Utilizing a newly developed energy yield model, we analyzed the performance of CIGS in various environmental scenarios, emphasizing its behavior in low-light conditions and under different temperature regimes. The model demonstrated high accuracy with improved error metrics of normalized mean bias error (nMBE) ~ 1% and normalized root mean square error (nRMSE) of  ~ 8%-20% in simulating rack mounted setup and integrated PV systems.

View Article and Find Full Text PDF

Background: Type 2 diabetes mellitus (T2DM) intensifies the clinical symptoms of heart diseases and leads to a worse prognosis in heart failure patients. Although hypertrophic cardiomyopathy (HCM) and DM rarely co-occur, particularly in older individuals, the impact of DM on cardiac function and outcomes in individuals with HCM remains insufficiently understood.

Methods: A total of 421 HCM patients were included and followed up in a prospective cohort study (mean 68.

View Article and Find Full Text PDF

For the purpose of determining the characteristics of the Cyanidin-3-O-glucoside chloride (COGC) dye, both an FT-IR spectrometer and a UV-Visible spect rometer were employed through the process. At a wavelength of 473 nm, a diode-pumped solid-state (DPSS) laser with an adjustable wavelength was used to quantify the thermally induced optical nonlinearity of the dye in a solvent composed of dimethylformamide. For the purpose of measuring the optical response, the Z-scan technique was utilised.

View Article and Find Full Text PDF

Introduction: The renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in regulating blood pressure (BP), with dysregulation of RAAS resulting in hypertension and potentially heart failure (HF), myocardial infarction (MI), cardio-renal syndrome, and stroke. RAAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs), have advantages beyond BP control. However, differences between these two drug classes need to be considered when choosing a therapy for preventing cardiovascular events.

View Article and Find Full Text PDF

Background: Enhancing prognostication in Hepatocellular Carcinoma (HCC) remains an unmet need, especially in patients with preserved liver function. This study aimed to integrate the Platelet-to-White Blood Cell Ratio (PWR) with albumin-bilirubin (ALBI) and platelets-albumin-bilirubin (PALBI) scores for improved assessment of mortality and treatment responses in hepatocellular carcinoma (HCC) patients.

Methods: In this prospective study, 262 patients with hepatocellular carcinoma (HCC) were included, with basic data collected and followed up for one year or until death.

View Article and Find Full Text PDF